Teladoc Health, Inc.

Halal Rating :
Comfortable
Last Price $7.1
Market Cap $1.24b
1D Change

3.03 %

1 Year Change

-32.99 %

Next Earnings Date

Yet to be announced

Company Overview

Teladoc Health is a multinational telemedicine and virtual healthcare company. The company provides telehealth services, virtual care, and integrated virtual care systems for health insurance companies, employers, and health care systems. Their primary services include primary care, mental health services, chronic condition management, and expert medical consultations.

Revenue Sources

Pass

Based on analysis of Teladoc's financial statements and business model, the company generates revenue primarily from subscription access fees and visit fees for telehealth services. These constitute legitimate services where real value is exchanged between the company and its customers. No revenue is derived from prohibited sources such as gambling, alcohol, tobacco, or other haram products and services.

Reliance on Interest

Reporting Date Total Revenue Total Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
March 31, 2025 $629.37m $755.75m - $5.76m 0.00% 0.76%
Dec. 31, 2024 $640.49m $688.71m - - 0.00% 0.00%
Sept. 30, 2024 $640.51m $690.57m - $5.66m 0.00% 0.82%
June 30, 2024 $642.44m $1.48b - - 0.00% 0.00%

Analysis of the last four quarters shows interest expenses ranging from $0 to $5.66 million per quarter against total expenses ranging from $690.57 million to $1.48 billion. The interest expense to total expense ratio remains consistently below 1% across all quarters, indicating interest plays an insignificant role in the company's operations.

Operational Ethics

Pass

After reviewing Teladoc's operations, partnerships, and locations, there is no evidence of significant ongoing associations with entities involved in human rights violations. The company does not maintain R&D centers or significant operations in Israel or have material ties to the Chinese Communist Party.

Rating Justification

Member Vote

Agree: 0 Disagree: 0

Login to vote on this

Comments

Recent News & Updates